Avoid Errors With Wegovy During Transitions of Care

You'll see patients admitted on the new weekly injectable semaglutide (Wegovy) for weight loss.

It's the same GLP-1 agonist as weekly injectable Ozempic or daily oral Rybelsus for type 2 diabetes.

Using Wegovy 2.4 mg weekly for about a year leads to roughly 10% to 12% more weight loss than with placebo, or 20 lb for a 200 lb patient.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals